TP53 mutations could also promote HCC cell proliferation, invasion, and metastasis while inhibiting apoptosis and DNA repair, thereby accelerating tumor progression and typically indicating a poor prognosis [29]. This evidence concerns the gene TP53 and hepatocellular carcinoma.